Roy Andrew Morgan
Direttore/Membro del Consiglio presso Stemina Biomarker Discovery, Inc.
Profilo
Roy Andrew Morgan is currently the Director at Stemina Biomarker Discovery, Inc., as well as the EVP-Regulatory Affairs & Quality Operations at both Zurex Pharma, Inc. and Zurex PharmAgra LLC.
Previously, he held positions as Director-Regulatory Affairs at Celltech Pharmaceuticals, Inc., VP-Regulatory, Quality & Pharmaceutical Sciences at Bone Care International, Inc., Vice President-Quality Operations at Genzyme Corp., and Manager-Regulatory Affairs & Labeling at Medeva Pharmaceuticals, Inc. Morgan received his undergraduate degree from Southwestern Oklahoma State University.
Posizioni attive di Roy Andrew Morgan
| Società | Posizione | Inizio |
|---|---|---|
Stemina Biomarker Discovery, Inc.
 Stemina Biomarker Discovery, Inc. BiotechnologyHealth Technology Stemina Biomarker Discovery, Inc. engages in the development and commercialization of molecular biomarkers to improve drug safety and human health. Its products and services include Cardio quickPredict, devTOX quickPredict, and TOXquickPredict. The company was founded by Elizabeth L. R. Donley and Gabriela G. Cezar in November 2006 and is headquartered in Madison, WI. | Direttore/Membro del Consiglio | - |
Zurex Pharma, Inc.
 Zurex Pharma, Inc. Medical SpecialtiesHealth Technology Zurex Pharma, Inc. provides safe and effective anti-microbial products. Its products include ZuraPrep, a pre-surgical skin preparation for the prevention of SSI; ZurAsept, an antimicrobial and antithrombotic catheter solution to reduce CRBSI; and ZuraGard that prevents extra-luminal or exit site wound CRBSI. The company was founded in April 2008 and is headquartered in Middleton, WI. | Consigliere Generale | - |
| Zurex PharmAgra LLC | Consigliere Generale | - |
Precedenti posizioni note di Roy Andrew Morgan
| Società | Posizione | Fine |
|---|---|---|
Bone Care International, Inc.
 Bone Care International, Inc. Pharmaceuticals: OtherHealth Technology Bone Care International, Inc. developed innovative therapeutic products. Its products included Hectorol Injections and Capsules. The company was located in Middleton, WI. | Consigliere Generale | - |
Medeva Pharmaceuticals, Inc.
 Medeva Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of UCB SA, Medeva Pharmaceuticals, Inc. is a pharmaceutical company that manufactures pharmaceutical products. The company is based in Rochester, NY. Medeva Pharmaceuticals was founded in 1998. | Consigliere Generale | - |
| Celltech Pharmaceuticals, Inc. | Consigliere Generale | - |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
Formazione di Roy Andrew Morgan
| Southwestern Oklahoma State University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 7 |
|---|---|
Bone Care International, Inc.
Bone Care International, Inc. Pharmaceuticals: OtherHealth Technology Bone Care International, Inc. developed innovative therapeutic products. Its products included Hectorol Injections and Capsules. The company was located in Middleton, WI. | Health Technology |
Stemina Biomarker Discovery, Inc.
Stemina Biomarker Discovery, Inc. BiotechnologyHealth Technology Stemina Biomarker Discovery, Inc. engages in the development and commercialization of molecular biomarkers to improve drug safety and human health. Its products and services include Cardio quickPredict, devTOX quickPredict, and TOXquickPredict. The company was founded by Elizabeth L. R. Donley and Gabriela G. Cezar in November 2006 and is headquartered in Madison, WI. | Health Technology |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
Zurex Pharma, Inc.
Zurex Pharma, Inc. Medical SpecialtiesHealth Technology Zurex Pharma, Inc. provides safe and effective anti-microbial products. Its products include ZuraPrep, a pre-surgical skin preparation for the prevention of SSI; ZurAsept, an antimicrobial and antithrombotic catheter solution to reduce CRBSI; and ZuraGard that prevents extra-luminal or exit site wound CRBSI. The company was founded in April 2008 and is headquartered in Middleton, WI. | Health Technology |
| Celltech Pharmaceuticals, Inc. | |
| Zurex PharmAgra LLC | |
Medeva Pharmaceuticals, Inc.
Medeva Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of UCB SA, Medeva Pharmaceuticals, Inc. is a pharmaceutical company that manufactures pharmaceutical products. The company is based in Rochester, NY. Medeva Pharmaceuticals was founded in 1998. | Health Technology |
- Borsa valori
- Insiders
- Roy Andrew Morgan
